A detailed history of Jane Street Group, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 204,335 shares of VXRT stock, worth $128,731. This represents 0.0% of its overall portfolio holdings.

Number of Shares
204,335
Holding current value
$128,731
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.58 - $0.99 $118,514 - $202,291
204,335 New
204,335 $173,000
Q1 2024

May 15, 2024

BUY
$0.56 - $1.41 $63,880 - $160,842
114,073 Added 530.03%
135,595 $176,000
Q4 2023

Feb 14, 2024

SELL
$0.57 - $0.85 $11,623 - $17,333
-20,392 Reduced 48.65%
21,522 $12,000
Q3 2023

Nov 14, 2023

SELL
$0.69 - $0.85 $112,445 - $138,519
-162,964 Reduced 79.54%
41,914 $31,000
Q2 2023

Aug 14, 2023

BUY
$0.6 - $1.41 $122,926 - $288,877
204,878 New
204,878 $149,000
Q4 2022

Feb 14, 2023

BUY
$0.75 - $2.24 $526,693 - $1.57 Million
702,258 Added 389.71%
882,456 $847,000
Q3 2022

Nov 14, 2022

BUY
$2.09 - $4.5 $67,586 - $145,521
32,338 Added 21.87%
180,198 $393,000
Q2 2022

Aug 16, 2022

BUY
$2.7 - $5.28 $204,387 - $399,690
75,699 Added 104.9%
147,860 $517,000
Q1 2022

May 17, 2022

SELL
$4.29 - $6.64 $36,143 - $55,942
-8,425 Reduced 10.45%
72,161 $365,000
Q4 2021

Feb 15, 2022

SELL
$5.77 - $7.96 $256,897 - $354,403
-44,523 Reduced 35.59%
80,586 $505,000
Q3 2021

Nov 16, 2021

BUY
$6.67 - $9.8 $157,005 - $230,682
23,539 Added 23.18%
125,109 $994,000
Q2 2021

Aug 16, 2021

BUY
$5.06 - $10.78 $194,364 - $414,081
38,412 Added 60.82%
101,570 $761,000
Q1 2021

May 18, 2021

SELL
$5.64 - $23.33 $1.53 Million - $6.34 Million
-271,727 Reduced 81.14%
63,158 $383,000
Q4 2020

Feb 17, 2021

BUY
$3.5 - $7.98 $784,301 - $1.79 Million
224,086 Added 202.25%
334,885 $1.91 Million
Q3 2020

Nov 17, 2020

SELL
$4.78 - $16.97 $451,126 - $1.6 Million
-94,378 Reduced 46.0%
110,799 $736,000
Q2 2020

Aug 17, 2020

BUY
$1.68 - $8.85 $344,697 - $1.82 Million
205,177 New
205,177 $1.82 Million

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $79.7M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.